Tus kws kho mob
P50-25 Reimbursement for MHCP Administration of Immunizations
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2025
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 621 - 630 ntawm 4139
Tus kws kho mob
P49-25 Requirement to Submit Appeals Via Availity Essentials
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2025
Tus kws kho mob
P48-25 Specialty Utilization Management (UM) Programs for Minnesota Health Care Program (MHCP) Products
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2025
Tus kws kho mob
P47-25 Prime Therapeutics Management (UM) Program: Medical Drug Updates
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2025
Tus kws kho mob
P46-25 New Medical and Behavioral Health Policy Management Updates, Effective October 6, 2025
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2025
Tus kws kho mob
QP60-25 MHCP Pharmacy Benefit Exclusion for Emrelis™, Jubbonti®, Pyzchiva®, Ryzneuta®, Wyost® and Zevaskyn™
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 09, 2025
Tus kws kho mob
QP59-25 Commercial Pharmacy Benefit Exclusion for Jubbonti®, Pyzchiva®, Ryzneuta®, Wyost® and Zevaskyn™
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 09, 2025